Contact
searchSearch
HMP Global
Login

October 2020

Department

Research in Review
Research in Review
10/21/2020
Despite Utility, NGS Testing for Cancer Often Denied Insurance Coverage Expanded genomic panel testing was clinically impactful in nearly two-third of patients with high-risk cancer, yet payers reimbursed only...
Despite Utility, NGS Testing for Cancer Often Denied Insurance Coverage Expanded genomic panel testing was clinically impactful in nearly two-third of patients with high-risk cancer, yet payers reimbursed only...
...
10/21/2020
Journal of Clinical Pathways

Column

Clinical Pathways Program Outcomes and User Experience
Editor's Page
Clinical Pathways Program Outcomes and User Experience
10/21/2020
Winston Wong, PharmD
The cancer care landscape continues to evolve. Not only do oncologists need to stay up to date on the latest treatment options for their patients, but also the age span of the general population is getting...
The cancer care landscape continues to evolve. Not only do oncologists need to stay up to date on the latest treatment options for their patients, but also the age span of the general population is getting...
The...
10/21/2020
Journal of Clinical Pathways
Trending From ACCC
Innovators Share How To’s for Practice Transformation
10/21/2020
In a recent “Ask the Board” column on how clinical pathways are growing, Journal of Clinical Pathways editorial advisory board member Ray Page, DO, PhD, FACOI, FASCO, shared his perspective: “As we continue to see...
In a recent “Ask the Board” column on how clinical pathways are growing, Journal of Clinical Pathways editorial advisory board member Ray Page, DO, PhD, FACOI, FASCO, shared his perspective: “As we continue to see...
In a...
10/21/2020
Journal of Clinical Pathways
Clinical Pathways GPS
Making the Case for Genetic Testing in Clinical Pathways
10/21/2020
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Medicare’s coverage for genetic testing is based on each test meeting a “reasonable and necessary” criteria. The decision on whether to order the test depends on real-world patient needs and what existing...
Medicare’s coverage for genetic testing is based on each test meeting a “reasonable and necessary” criteria. The decision on whether to order the test depends on real-world patient needs and what existing...
...
10/21/2020
Journal of Clinical Pathways

Feature

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival
Research Reports
Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival
10/21/2020
Aimee Ginsburg, PharmD, BCPS; J. Russell Hoverman, MD, PhD; Angela Hsieh, PharmD, BCOP; Kartik Konduri, MD; Leslie T. Busby, MD; Lalan Wilfong, MD; John M. Burke, MD; Marcus A. Neubauer, MD
Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...
Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...
...
10/21/2020
Journal of Clinical Pathways
Supporting Optimal, Value-Based, and Sustainable Cancer Care Delivery
Perspectives
Supporting Optimal, Value-Based, and Sustainable Cancer Care Delivery
10/21/2020
Anita Pudusseri, DO; Paul J. Hesketh, MD; Sylvia Richey, MD; Lee Schwartzberg, MD, FACP; Rebecca Stein; Wui-Jin Koh, MD; Tyler Haydell; Corrine Zarwan, MD; Barbara McAneny, MD; Alison Fugaro, PA; Edward Arrowsmith, MD
Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...
Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...
...
10/21/2020
Journal of Clinical Pathways
JCP January/February 2025

Current Issue

February 2025
Volume 11
Issue 1
Current Issue
Issue Archive

Special Reports

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 6

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use